International Journal of NeuroscienceHorwitz B. Neuroplasticity and the progression of Alzheimer’s disease . Int J Neurosci (1988) 41 :1–1410.3109/00207458808985737 [ Cross Ref ]Horwitz B.Neuroplasticity and the progression of Alzheimer‘s disease. International Journal of Neuroscience . 1988...
Rialle, "Modeling the progression of Alzheimer's disease for cognitive assistance in smart homes," User Modeling and User-Adapted Interaction, vol. 17, pp. 415-38, 2007.A. Serna, H. Pigot and V. Rialle, "Modeling the progression of Alzheimer's disease for cognitive assistance in smart ...
a有什么可以帮到你? What has to be possible to help you?[translate] aIn fact, memantine is widely used in therapeutics to slow down the progression of Alzheimer’s disease。 实际上, memantine是用途广泛在治疗学方面减速Alzheimer的疾病进步。[translate]...
Monitoring the progression of Tau pathology makes it possible to study the clinical diversity of Alzheimer’s disease. In this 2-year longitudinal PET study, we aimed to determine the progression of [18F]-flortaucipir binding and of cortical atrophy, and their relationships with cognitive decline...
The stages don't always fall into neat boxes, and the symptoms might vary. But they can be a guide and help you plan for your friend or relative's care. Doctors call these different stages the progression of the disease. There is no cure for Alzheimer's disease, so understanding what ...
The reconceptualization of Alzheimer’s disease (AD) as a clinical and biological construct has facilitated the development of biomarker-guided, pathway-based targeted therapies, many of which have reached late-stage development with the near-term potential to enter global clinical practice. These medic...
Statins could slow the progression of Alzheimer's disease, at least for some patients. This is the result of a new study led by Karolinska Institutet published in Alzheimer Research and Therapy. But the researchers are cautious in their interpretations a
A neurobiological hypothesis is proposed to explain the relation between the percentage cell loss in the cholinergic basal forebrain and the density of neuritic plaques in cortex, as found by Arendt et al. (1985) in Alzheimer''s disease: When cells in the cholinergic basal forebrain die, their...
G. Local neuroinflammation and the progression of Alzheimer's disease. J. Neurovirol. 8, 529-538 Postmortem immunohistochemical studies have revealed a state of chronic inflammation limited to lesioned areas of brain in Alzheimer's disease. Some key actors in this inflammation are activated ...
"Infectious agents have been implicated in the development and progression of Alzheimer's disease before, but the evidence of causation hasn't been convincing," Dominy said at the time. Dominy表示, “传染性物质曾经被认为与阿兹海默症的发生和加重有关,但是关于成因却一直缺乏令人信服的证据。” ...